Across TCGA pan-cancer cohorts, COA7 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated COA7 data layer compared with 5 for mutation status and 6 for mass-spec protein.
The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher COA7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated COA7 expression acts as an unfavorable survival marker, although some lineages such as KIRC and READ show a favorable association.
LIHC, KIRP, and ACC are the cancer types where COA7 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.